These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22035432)

  • 41. Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
    Kotyla PJ
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Position on choice of agents among TNF inhibitors].
    Manger B;
    Z Rheumatol; 2005 Mar; 64(2):88-9. PubMed ID: 15793672
    [No Abstract]   [Full Text] [Related]  

  • 43. Promoting science over serendipity in prescribing anti-TNF therapy.
    Chee MM; Alcorn N; Paterson K; Madhok R
    Rheumatology (Oxford); 2009 Aug; 48(8):865-6. PubMed ID: 19403738
    [No Abstract]   [Full Text] [Related]  

  • 44. Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience.
    Kaushik VV; Ambalavanan S; Binymin K
    Rheumatology (Oxford); 2007 Dec; 46(12):1863-4; author reply 1864-5. PubMed ID: 17965441
    [No Abstract]   [Full Text] [Related]  

  • 45. TNF antagonists opened the way to personalized medicine in rheumatoid arthritis.
    Breedveld F
    Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S7-9. PubMed ID: 25549234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathophysiological advances underlying the biotherapeutic revolution in inflammatory rheumatism].
    Mariette X
    Bull Acad Natl Med; 2012 Oct; 196(7):1261-76; discussion 1276-8. PubMed ID: 23815013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of TNF α antagonist therapy on bone metabolism in rheumatoid arthritis: a systematic review.
    Sakthiswary R; Das S
    Curr Drug Targets; 2013 Dec; 14(13):1552-7. PubMed ID: 23848441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tailored approach to rheumatoid arthritis treatment with TNF inhibitors: where do we stand?
    Caporali R; Codullo V; Cipriani P; Giacomelli R
    Rheumatology (Oxford); 2018 Oct; 57(57 Suppl 7):vii1-vii4. PubMed ID: 30289536
    [No Abstract]   [Full Text] [Related]  

  • 49. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus?
    Danve AS; Kulkarni S
    Am J Ther; 2017 May; 24(3):e347-e350. PubMed ID: 26103543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of dosing on treatment with TNF inhibitors: managing dose adjustment.
    Combe B
    Clin Exp Rheumatol; 2010; 28(3 Suppl 59):S13-7. PubMed ID: 20576220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
    Bek S; Bojesen AB; Nielsen JV; Sode J; Bank S; Vogel U; Andersen V
    Pharmacogenomics J; 2017 Oct; 17(5):403-411. PubMed ID: 28607508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis.
    Mok CC; Tsai WC; Chen DY; Wei JC
    Expert Opin Biol Ther; 2016; 16(2):201-11. PubMed ID: 26560845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progress toward personalized treatment of rheumatoid arthritis.
    Keith MP; Edison JD; Gilliland WR
    Clin Pharmacol Ther; 2012 Oct; 92(4):440-2. PubMed ID: 22910444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in use of immunomodulatory agents--a rheumatology perspective.
    Her M; Kavanaugh A
    Nat Rev Gastroenterol Hepatol; 2015 Jun; 12(6):363-8. PubMed ID: 25895821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ACP Journal Club: combination intensive DMARD therapy is noninferior to TNF inhibitors for reducing disability in active RA.
    McLeod BD
    Ann Intern Med; 2015 Aug; 163(4):JC9. PubMed ID: 26280444
    [No Abstract]   [Full Text] [Related]  

  • 56. New therapeutic approaches in rheumatoid arthritis.
    van Vollenhoven RF
    Presse Med; 2016 Jun; 45(6 Pt 2):e179-92. PubMed ID: 27242206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing new therapies for RA: defining new expectations for treatment. New therapies in clinical practice: issues of cost and access.
    Am J Manag Care; 1999 Jun; 5(8 Suppl):S502-5. PubMed ID: 10538857
    [No Abstract]   [Full Text] [Related]  

  • 58. ACP Journal Club: review: some TNF inhibitors increase adverse events in patients with rheumatoid arthritis.
    Sacks HS
    Ann Intern Med; 2015 Apr; 162(8):JC10. PubMed ID: 25894043
    [No Abstract]   [Full Text] [Related]  

  • 59. TNF alpha blockade in rheumatoid arthritis--time for caution or enthusiasm?
    Hamilton JD; Wilson HE; Madhok R; McInnes IB; Capell HA
    Scott Med J; 2001 Jun; 46(3):67-70. PubMed ID: 11501322
    [No Abstract]   [Full Text] [Related]  

  • 60. Kinase inhibitors for the treatment of rheumatoid arthritis.
    Yazici Y; Steiger B
    Bull NYU Hosp Jt Dis; 2012; 70(3):204-7. PubMed ID: 23259630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.